Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Nomir Medical's Noveon(R) Device Achieves 76 Percent Response Rate In Pivotal Trial For The Treatment Of Onychomycosis
Nomir Medical's Noveon(R) Device Achieves 76 Percent Response Rate In Pivotal Trial For The Treatment Of Onychomycosis
Nomir Medical's Noveon(R) Device Achieves 76 Percent Response Rate In Pivotal Trial For The Treatment Of Onychomycosis
Submitted by
admin
on March 8, 2009 - 12:46pm
Source:
Medical News Today
News Tags:
Onychomycosis
Nomir Medical
Headline:
Nomir Medical's Noveon(R) Device Achieves 76 Percent Response Rate In Pivotal Trial For The Treatment Of Onychomycosis
Do Not Allow Advertisers to Use My Personal information
